Strengthening human papillomavirus vaccination programs through multi-country peer learning: lessons from the CHIC initiative

References

1. 1.↵
   2. Wu J,
   3. Jin Q,
   4. Zhang Y,
   5. Ji Y,
   6. Li J, et al.

   Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022. J Natl Cancer Center. 2025; 5: 322–9.

   OpenUrl
2. 2.↵
   World Health Organization. HPV Vaccine Introduction Clearing House [Internet]. [cited 2025 Jul 14]. Available from: https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)/hpv-clearing-house
3. 3.↵
   World Health Organization. HPV Dashboard [Internet]. [cited 2025 Aug 19]. Available from: https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)/hpv-clearing-house/hpv-dashboard
4. 4.↵
   World Health Organization. Cervical Cancer Elimination Initiative [Internet]. [cited 2025 Jul 14]. Available from: https://www.who.int/initiatives/cervical-cancer-elimination-initiative
5. 5.↵
   stophpv.org [Internet]. CHIC: Coalition to Strengthen the HPV Immunization Community; [cited 2024 Jan 4]. Available from: https://stophpv.org/about/
6. 6.↵
   2. Bolio A,
   3. Waheed DE,
   4. Mugo N,
   5. Garland SM,
   6. Wanyoike S,
   7. Njambe Tondo Opute E, et al.

   Overview of CHIC symposia series: summary of Africa and South Asia symposia. Vaccine. 2024; 42: S9–15.

   OpenUrl
7. 7.↵
   2. Ndiaye C,
   3. Kyesi F,
   4. Masupha T,
   5. Ranyali M,
   6. Engel D,
   7. Guillaume D, et al.

   Integrating HPV vaccine service delivery with adolescent health programs – experiences and perspectives from selected countries in Africa. Vaccine. 2024; 42: S45–8.

   OpenUrlPubMed
8. 8.↵
   2. Stanley M,
   3. Schuind A,
   4. Muralidharan KK,
   5. Guillaume D,
   6. Willens V,
   7. Borda H, et al.

   Evidence of an HPV one-dose schedule. Vaccine. 2024; 42: S16–21.

   OpenUrlPubMed
9. 9.↵
   2. Sidibe A,
   3. Kouassi KS,
   4. Ekra D,
   5. Bloem P,
   6. Mtonga VC,
   7. Morgan C, et al.

   Accelerating and broadening multisectoral partnerships for introducing and rebuilding HPV vaccination programs. Vaccine. 2024; 42: S41–4.

   OpenUrlPubMed
10. 10.↵
    2. Burdier FR,
    3. Bolio A,
    4. Abraham P,
    5. Pimple S,
    6. Franco EL,
    7. Pempa P, et al.

    Case studies on the progress in cervical cancer screening programs in Bhutan, India, and Türkiye. Vaccine. 2024; 42: S49–53.

    OpenUrlPubMed
11. 11.↵
    2. Borda H,
    3. Bloem P,
    4. Akaba H,
    5. Guillaume D,
    6. Willens V,
    7. Jurgensmeyer M, et al.

    Status of HPV disease and vaccination programs in LMICs: introduction to special issue. Vaccine. 2024; 42(Suppl 2): S1–8.

    OpenUrl
12. 12.↵
    2. Waheed DEN,
    3. Bolio A,
    4. Kyesi F,
    5. Miano CW,
    6. Tefera YL,
    7. Kinteh M, et al.

    Routine HPV vaccination: reflection on delivery strategies based on countries’ experiences. Vaccine. 2024; 42: S37–40.

    OpenUrlCrossRefPubMed
13. 13.↵
    2. Waheed DEN,
    3. Mumba M,
    4. Alfred D,
    5. Bogale M,
    6. Rujumba J,
    7. Bakeera-Kitaka S, et al.

    Identifying key challenges and optimizing approaches for training of health care professionals for HPV vaccination programs. Vaccine. 2024; 42: S22–6.

    OpenUrlPubMed
14. 14.↵
    2. Njogu R,
    3. Deb Roy A,
    4. Bagudu Z,
    5. Borda H,
    6. Jurgensmeyer M,
    7. Muralidharan K, et al.

    Effective communication by health care workers to promote HPV vaccination: lessons learned from Kenya, India, and Nigeria. Vaccine. 2024; 42: S27–32.

    OpenUrlPubMed
15. 15.↵
    2. Kouassi KS,
    3. Chisupa E,
    4. Clarke A,
    5. Massenon I,
    6. Miano C,
    7. Mutuku F, et al.

    Pandemic-associated resilience in HPV vaccination programs – perspectives from selected countries in Africa on what it will take to vaccinate 90% of girls by 2030. Vaccine. 2024; 42: S33–6.

    OpenUrlCrossRefPubMed